Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
about
Drugs versus placebo for dysthymiaDrugs versus placebo for dysthymiaTrajectories of Functioning Into Emerging Adulthood Following Treatment for Adolescent Depression.The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.Australian and New Zealand clinical practice guidelines for the treatment of depression.The clinical and occupational correlates of work productivity loss among employed patients with depressionShould we treat depression with drugs or psychological interventions? A reply to Ioannidis.Poor response to treatment: beyond medication.Managing depression-related occupational disability: a pragmatic approach.Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaLong-term social functioning after depression treated by psychiatrists: a review.Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.Meta-analysis of relapse prevention antidepressant trials in depressive disorders.Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment.Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence.Economic factors in of patients' nonadherence to antidepressant treatment.ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.Factors associated with subjective quality of life in Korean patients with depressive disorders: the CRESCEND study.Soziale Kognition bei PatientInnen mit affektiven Störungen: Teil I: Unipolar Depressive Störung
P2860
Q24187378-3F02DFB5-D87F-418C-843D-70DBA0102FF8Q24246945-5D566DD9-8E4C-4558-A2D8-42C8E264EFA6Q30353906-183529F5-8164-47D2-91E7-72650F702B16Q33622133-BE1B30EB-7749-450E-BD9B-7BCCBBBE4C6BQ34548787-6572B7F0-B449-4FA0-ADD5-899771E203BAQ34820452-FE980B0E-A969-447B-AE17-ECB9B77AC6CEQ35069464-54BE9F05-9E6A-42BB-B786-83C1E42132A7Q35236765-B4CA3F9C-BD9B-41E1-943B-E5D1B8404D08Q36600040-579162D3-5248-46BC-9988-75E64DA8EC45Q36627458-86A8EE4C-E752-43FC-8D6F-A1A38364880FQ36772958-B530CDA0-6D31-47DC-9C21-0104BA1E6DF9Q36889128-FE5AD7F9-CAB9-42C3-90A6-7B7B285A0A3EQ36995148-723C667E-19F1-4AF9-91DB-FC15B624AB88Q37773366-609D95D2-B055-403B-B562-1955215A6305Q38616095-183717BC-B433-45BC-97B2-9FA925F85572Q38649590-E54B1FB6-9F71-4DDB-9A7B-96AEE6795C80Q43443984-BDDBEE7F-3B1C-43DE-B2B0-A57F4556C2B0Q47578748-C4F7C655-73EB-46E0-8AE7-B04214F0D9A7Q48590042-1EA4E3E9-52C9-47A9-AD58-105847761141Q57847497-1DD6EBEC-08A8-4F07-8DDE-C22E21A91010
P2860
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Psychosocial outcomes followin ...... on with sertraline vs placebo.
@en
Psychosocial outcomes followin ...... on with sertraline vs placebo.
@nl
type
label
Psychosocial outcomes followin ...... on with sertraline vs placebo.
@en
Psychosocial outcomes followin ...... on with sertraline vs placebo.
@nl
prefLabel
Psychosocial outcomes followin ...... on with sertraline vs placebo.
@en
Psychosocial outcomes followin ...... on with sertraline vs placebo.
@nl
P2093
P1433
P1476
Psychosocial outcomes followin ...... on with sertraline vs placebo.
@en
P2093
A John Rush
Alan Schatzberg
Daniel N Klein
James H Kocsis
Leah Gniwesch
Sonia M Davis
Wilma Harrison
P304
P356
10.1001/ARCHPSYC.59.8.723
P407
P577
2002-08-01T00:00:00Z